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SUMMARY  
In mammals, DNA methylation occurs mainly at CpG dinucleotides. The 
methylation on the promoter leads to the suppression of gene 
expression, while the functional role of gene body DNA methylation in 
highly expressed genes has yet to be clarified.  
Here, we show that the Dnmt3b-dependent intragenic DNA methylation 
protects the gene body from RNA Polymerase II spurious entry and 
cryptic transcription initiation. Using different genome-wide approaches, 
we demonstrate that this Dnmt3b function is dependent on its enzymatic 
activity and recruitment on the gene body by H3K36me3. Furthermore, 
the spurious transcripts can be either degraded by the RNA exosome 
complex or capped, polyadenylated, and delivered to the ribosome to 
produce aberrant proteins.  
Thus, elongating RNA Polymerase II triggers an epigenetic crosstalk 
that involves SetD2, H3K36me3, Dnmt3b, and DNA methylation to 
ensure gene transcription initiation fidelity with implications for 
intragenic hypomethylation in cancer.   
 
 
DNA methylation of cytosine residues on CpGs is a heritable epigenetic 
modification crucial for mammalian development that involves the coordinated 
processes of DNA methylation, demethylation, and maintenance of the 
methylated cytosine1-4. De novo establishment of DNA methylation is 
regulated by the DNA methyltransferases Dnmt3a and Dnmt3b alone or in a 
complex with Dnmt3l, whereas DNA methylation maintenance is mediated by 
Dnmt15-9.  
 3 
The methylation of gene promoters is associated with gene silencing, while 
the function of gene body DNA methylation has not yet been clarified. Recent 
studies have reported that Dnmt3b binds preferentially to the gene bodies by 
interacting with the histone modification H3K36me310,11. In this study, we took 
advantage of Dnmt3b specificity to target intragenic DNA methylation with the 
aim to clarify the function DNA methylation within the gene body.   
 
 
Dnmt3b loss reduces gene body DNA methylation  
To gain insights into the functional role of Dnmt3b-dependent intragenic DNA 
methylation, we generated two independent Dnmt3b knockout cell lines from 
mouse embryonic stem cell (ESC) line E14 to exclude experimental artefacts 
due to different genetic backgrounds, or prolonged cell culturing (Extended 
Data Fig. 1a-f). Next we investigated the distribution of the endogenous 
Dnmt3b. ChIP-seq analysis revealed the intragenic binding of the endogenous 
Dnmt3b especially on the genes belonging to the third and fourth quartiles 
(q3-q4) of gene expression and correlated with H3K36me3 histone 
modification (Fig. 1a-c and Extended Data Fig 1g-q). Whole genome bisulfite 
sequencing (WGBS) in WT or Dnmt3b-/- ESCs revealed a global reduction of 
genomic DNA methylation, with a significant decrease of the level of 5-
methylcytosine (5mC) on exons and introns (Fig. 1d and Extended Data 
Fig. 1r). Genome splitting in deciles of H3K36me3 occupancy showed that 
both Dnmt3b binding and DNA methylation loss in Dnmt3b-/- cells markedly 
correlate with the abundance of H3K36me3 (Fig. 1e).  
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Analysis of intragenic spurious transcription 
During the transcriptional elongation, the RNA polymerase II (RNA Pol II) 
recruits the enzyme SetD2 across the transcribed regions for H3K36 
trimethylation12,13, which has been demonstrated to maintain a repressive 
chromatin environment to prevent  spurious entry of the RNA Pol II14. In yeast, 
the repressive action of H3K36me3 is mediated by the recruitment of histone 
deacetylases (HDACs) that make the chromatin inaccessible15. Silencing of 
SetD2 in mammalian cells leads to cryptic transcription initiation of a large 
fraction of active genes. However, no change in histone acetylation levels 
occurs after SetD2 knockdown12,14,16.  
To investigate the functional role of the Dnmt3b-dependent DNA methylation 
on gene bodies, we performed a high-coverage total RNA-seq analysis in WT 
and Dnmt3b-/- ESCs (Extended Data Fig. 2a, b). The occurrence of cryptic 
intragenic transcription initiation was measured by the ratio between the 
RPKM of the intermediate exons and the RPKM of the first exon. Dnmt3b-/- 
cells displayed a significantly higher ratio starting from the second exon (Fig. 
2a). 1445 genes (18% of total genes having RPKM > 1) had a log2 ratio of 
intermediate exons versus first exon > 1 (Fig. 2b). Analysis performed on 
technical and biological replicates, and validation by RT-qPCR on a subset of 
genes confirmed this result (Extended Data Fig. 2c-e). This indicates that in 
Dnmt3b-/- cells, a significant amount of RNAs are transcribed starting within 
the gene body.  
Intragenic DNA methylation can regulate alternative promoters17. To test this 
hypothesis we investigated the promoter usage of genes having two or more 
annotated alternative promoters. Even though some alternative promoters’ 
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reactivation events take place in Dnmt3b-/- cells, the Dnmt3b loss did not show 
evidence of a general reactivation of these events at genome-wide level 
(Extended Data Fig. 3).  
Activation of cryptic intragenic transcription initiation events can be a 
consequence of RNA Pol II spurious entry on the gene body. To test this, we 
performed ChIP-seq analysis of RNA Pol II and H3K36me3 in WT and 
Dnmt3b-/- cells. To distinguish between the engaged and the elongating RNA 
Pol II, we treated the cells with 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole 
(DRB), a chemical compound that inhibits transcription elongation18 19. We 
then performed ChIP-seq using two different antibodies recognizing pan RNA 
Pol II or the RNA Pol II phosphorylated on Serine 5 (Ser5), both of which are 
able to immunoprecipitate stalled RNA Pol lI (Extended Data Fig. 4a-c). We 
did not observe any significant changes in H3K36me3 and RNA Pol II 
genomic profiles when comparing untreated WT to Dnmt3b-/- cells (Fig. 2c, d 
and Extended Data Fig. 4d-f). In contrast, we observed a significant increase 
of RNA Pol II binding on intragenic regions when comparing Dnmt3b-/- to WT 
cells treated with DRB. This was especially true on introns and exons of q3-q4 
genes using both antibodies (Fig. 2c, d and Extended Data Fig. 4f) with a 
small but detectable increment of H3K4me3 and H3ac on the q4 genes 
(Extended Data Fig. 4g-j). These data strongly support the hypothesis that 
Dnmt3b is necessary to prevent intragenic spurious transcription initiation by 
repressing RNA Pol II entry downstream the canonical promoters. 
To confirm the increase of intragenic transcription activation in Dnmt3b-/- cells, 
we performed an RNA immunoprecipitation with a CAP-specific antibody20 
that was followed by high-throughput sequencing (CAPIP-seq) (Extended 
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Data Fig. 5a-e). Application of this technique to total RNA, showed a 
significant enrichment of CAP signal in intermediate intronic and exonic 
regions of Dnmt3b-/- transcripts (Extended Data Fig. 5f-g).  
Since the Pol II ChIP-seq and CAPIP-seq are affinity-purification methods, 
which suffer of high backgrounds and lack the resolution power to map the 
start sites at single-base resolution, we performed a high-throughput 
identification of the transcriptional start sites at single-base resolution in WT 
and Dnmt3b-/- cells using the RNA 5' Pyrophosphohydrolase (RppH) enzyme 
to decap eukaryotic mRNAs, leaving a 5´ monophosphate group21 that was 
selectively used for adapter ligation to map the CAP signals, transcriptome-
wide (DECAP-seq) (Extended Data Fig. 6a-e). DECAP-seq analysis in WT 
and Dnmt3b-/- cells revealed a significant increase of the transcription start 
sites (TSSs) in Dnmt3b-/- cells with respect to WT cells on the gene bodies of 
the q3 and q4 genes (Fig. 3a, b and Extended Data Fig. 6f, g). Since the 
average RPM value on each single-base TSS on annotated TSSs is around 6 
(Extended Data Fig. 6h-j), we further analysed the single-base intragenic 
TSSs having RPM > 6. This analysis identified 2627 highly expressed TSSs 
(RPM > 6) specific of the Dnmt3b-/- cells, 780 TSSs common in both the cell 
lines and 936 specific of WT cells (Fig. 3c). The percentage of the total 
mapped reads specific for Dnmt3b-/- TSSs was 2.76%, while the percentage 
of common TSSs was 5.22% suggesting that these latter represent canonical 
TSSs not present in the used gene annotation (Fig. 3d). The number of 
intragenic TSSs and the reads distribution was similar in both the DECAP-seq 
replicates showing high overlap (Extended Data Fig. 6k-m) and were 
confirmed by significant enrichment of CAPIP-seq and Pol II ChIP-seq as well 
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as by an increased RNA-seq ratio between downstream vs upstream exons in 
the KO cells (Extended Data Fig. 16n-o).  
The intragenic TSSs identified in Dnmt3b-/- cells were within genomic regions 
with significantly higher H3K36me3 and Dnmt3b binding, showed loss of 
methylation upon Dnmt3b depletion, and lower nucleosome occupancy with 
respect to randomly chosen intragenic regions (Fig. 3e). The latter 
observation is in agreement with the recent finding on Dnmt3b enzymatic 
preference to the linker DNA10,11.  
To get an insight of the mechanism that generates the cryptic intragenic 
transcripts, we next analysed the sequence context where the spurious 
intragenic TSSs are generated. It has been previously shown that mammalian 
transcription preferentially starts with a pyrimidine (C/T) at position -1 and with 
a purine (A/G) at position +122. Our data confirm this observation on canonical 
TSSs, while on intragenic TSSs we observed the loss of the pyrimidine 
enrichment at position -1 and a reduced enrichment of the purine at position 
+1 (Fig. 3f). Interestingly, within a region of 50 bp centred at the Dnmt3b-
dependent intragenic TSSs, we found a statistically significant enrichment of 
the CpG dinucleotide and several transcription factor binding motifs containing 
CpG sequence, including SP1 and members of the ETS family (Fig. 3g, h and 
Extended data Fig. 7a). Since both SP1 and ETS proteins can recruit the 
transcription machinery in TATA-less promoters, and their binding to the DNA 
is affected by CpG methylation23-28, we verified the presence of their motif on 
some example TSSs identified by the DECAP-seq analysis (Fig. 3i and 
Extended Data Fig. 7b).  
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First, we confirmed the presence of these cryptic TSSs with targeted CAP-
immunoprecipitation and RNA Pol II ChIP experiments as well as with RT-
qPCR by measuring the RNA level of the downstream/upstream exon of the 
intragenic TSSs and validated the differential methylation between WT and 
Dnmt3b-/- cells by using bisulfite Sanger sequencing (Extended Data 
Fig. 7c, d).   We observed the enrichment of Tbp, TfIIb, Sp1, Elk1 and/or Elf1 
by ChIP experiments on the cryptic TSSs, but not in the control region 
(Extended Data Fig. 7e). 
 
 
Crosstalk between H3K36me3 and DNA methylation 
To demonstrate the involvement of the H3K36me3 histone mark in this 
molecular event, we silenced SetD2 and measured the activation of cryptic 
TSSs in WT and Dnmt3b-/- cells. SetD2 knockdown resulted in a drastic 
reduction of H3K36me3 both in WT and Dnmt3b-/- cells and loss of Dnmt3b 
intragenic binding in WT cells (Fig. 4a-c and Extended Data Fig. 8a-f). The 
intermediate/first exon ratio in SetD2 silenced with respect to the control cells 
estimated by total RNA-seq showed an increase of spurious transcripts that 
was comparable to the increase measured in Dnmt3b-/- versus WT cells (Fig. 
4d, e and Extended Data Fig. 8 g, h). DECAP-seq revealed a significant 
increase of TSSs in SetD2 silenced cells with respect to control cells on the 
gene bodies of the transcripts belonging to the genes q3 and q4 (Extended 
Data Fig. 8i-k). This analysis revealed 3560 high confident (RPM > 6) 
intragenic TSSs in SetD2 silenced cells, of which 2759 were specific of the 
SetD2 knockdown and more than 2000 were in common with the TSSs 
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identified in Dnmt3b-/- cells (Extended Data Fig. 8l-o and 9a). Thus, Dnmt3b-
mediated inhibition of spurious transcription initiation is dependent on the 
presence of H3K36me3.  
Next we investigate whether this mechanism depends on the catalytic activity 
of Dnmt3b, we expressed either the full-length WT Dnmt3b enzyme or the 
catalytically inactive mutant (V725G)29 form into Dnmt3b-/- cells (Fig. 4f). Both 
the Dnmt3b proteins showed similar intragenic binding profiles (Fig. 4g, h and 
Extended Data Fig. 9b, c), although only the cells expressing the WT protein 
showed an increase of DNA methylation levels (Extended Data Fig. 9d, e). 
Total RNA-seq (Extended Data Fig. 9f, g) revealed a significant reduction of 
the intermediates/first exon ratio in the cells expressing the WT Dnmt3b 
enzyme, but not in those expressing Dnmt3bV725G mutant (Fig. 4i, j). To 
further confirm the importance of the H3K36me3-mediated recruitment of the 
active Dnmt3b on the gene bodies we also expressed mutants (S277P and 
VW-RR) unable to bind H3K36me3 (Extended Data Fig. 9h)10. These Dnmt3b 
mutants showed lower intragenic binding with reduced DNA methylation 
activity (Extended Data Fig. 9i, j) and were unable to reduce the 
intermediates/first exon ratio (Extended Data Fig. 10a-d).  Thus, only the re-
expression of the WT Dnmt3b was able to rescue the loss of spurious 
intragenic transcription initiation in Dnmt3b-/- cells demonstrating that Dnmt3b-
dependent DNA methylation is responsible for preventing the occurrence of 
cryptic intragenic transcription. 
 
Analysis of spurious transcripts 
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Next, we analysed the fate of the cryptic RNAs generated by spurious 
intragenic initiation events.  To this end we first analysed whether these RNAs 
are degraded. Silencing of the Dis3 and Rrp6 component of the RNA 
exosome complex did not show changes in the total number of intragenic 
TSSs (Extended Data Fig. 10e-g), but a significant increase of their 
expression level (Extended Data Fig. 10h-k). Thus, indicating that a fraction of 
the cryptic transcripts generated in Dnmt3b-/- cells is degraded by the RNA 
exosome complex.  Although analysis of the polyA+ transcripts by RNA-seq 
(Extended Data Fig. 10l, m) showed an increase of the intermediate/first exon 
ratio in Dnmt3b-/- cells (Fig. 5a, b and Extended Data Fig. 10n, o) showing that 
the intragenic transcripts are, at least in part, polyadenylated.     
To investigate the stability of these aberrant RNAs, and to follow their fate, we 
performed DECAP-seq from PolyA-enriched and cytoplasmic RNA. We found 
a significant reduced number of intragenic TSSs in PolyA+ and cytosolic 
DECAP-seq with respect to DECAP-seq starting from total RNA (Extended 
Data Fig. 10p, q) confirming that a fraction of the spurious transcripts is 
actually degraded and indicating that not all cryptic transcripts undergo 
polyadenylation and nuclear export. Interestingly, almost all the highly 
expressed TSSs identified in Dnmt3b-/- cells can be found in the PolyA+ and 
cytosolic DECAP-seq fractions (Fig. 5c), even though, with a significantly 
lower level of expression with consequent reduction of the percentage of the 
total mapped reads (Fig. 5d, e), while highly expressed common TSSs do not 
globally change their expression among the different cellular compartments 
(Extended Data Fig. 10r, s).  
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To further measure the stability of the PolyA+ cryptic RNAs, we estimated the 
mRNA half-life in WT and Dnmt3b-/- cells by performing polyA+ RNA-seq 
analyses in DRB-treated cells at different time points30   (Extended Data Fig. 
11a-b). The intronic RNA inclusion in Dnmt3b-/- cells remained always higher 
than in WT cells along the time course (Fig. 5f) and the intronic RNA half-life 
slightly increased in Dnmt3b-/- cells (Extended Data Fig. 11d, f) whereas the 
whole transcriptome half-life did not show any significant difference between 
WT and Dnmt3b-/- cells (Extended Data Fig. 11c, e, g). Moreover, the 
intermediates/first exon ratio was higher in Dnmt3b-/- with respect to WT cells 
at all time points of DRB treatment (Fig. 5g, h), revealing that the spurious 
RNAs, once polyadenylated, are as stable as the full length RNAs transcribed 
from canonical TSSs.  
To characterize the biological impact of the cryptic transcripts we investigated 
their post-transcriptional processing by performing mRNA ribosome profiling31 
(Extended Data Fig. 11h, i). Active mRNA Translation sequencing (ART-seq) 
revealed that Dnmt3b-/- cells displayed a significant reduction of the ribosome 
occupancy on the 5’-UTR region together with a marked increase in the 
occupancy of RNA intronic regions, especially on q3-q4 genes (Fig. 5i, j and 
Extended Data Fig. 11j, k), while we did not observe significant changes in the 
ribosome enrichment of the coding region of the transcripts between WT and 
Dnmt3b-/- cells (Fig. 5i and Extended Data Fig. 11j). Thus, suggesting that the 
increment of RNA Pol II spurious entry and consequent transcription of cryptic 
RNAs might generate aberrant proteins.  
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Discussion 
DNA methylation takes place both at the promoters and within the gene body. 
While it is well documented that DNA methylation at the promoters is 
associated with gene silencing, the function of gene body DNA methylation 
remains elusive. We now demonstrate that Dnmt3b-dependent DNA 
methylation on the gene body is responsible for the prevention of aberrant 
transcription initiation events necessary to guarantee the mRNA transcription 
initiation fidelity (Extended Data Fig. 12a). Previous studies reported 
examples of alternative splicing or activation of  retroviruses  due to intragenic 
DNA methylation32-34. We tested these hypotheses and, in agreement with the 
literature, we found few events of alternative splicing and activation of 
repetitive elements actually occurring in Dnmt3b-/- cells (data not shown). 
However, these regulations were sporadic in our model.  
Our work, unveiling the functional role of the epigenetic crosstalk between 
RNA Pol II, H3K36me3, and DNA methylation (Extended Data Fig. 12b), can 
explain physiological gene regulation as well as the occurrence of abnormal 
transcripts in cancer. Indeed, the global DNA hypomethylation, especially 
occurring on intragenic regions, is a general feature of most tumours35-37. 
Moreover, several recent studies reported the loss/mutation of SETD2 and the 
consequent loss of H3K36me3 histone mark as a key event in promoting 
cancer growth and malignancy38-40. The present study reveals a novel 
function of intragenic DNA methylation and provides new aspects that have to 
be considered in evaluating the roles of SETD2 and DNMT3B in cancer 
establishment and progression. Partial internal RNAs generated by the loss of 
transcription initiation fidelity, could impact on multiple biological processes 
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impairing molecular mechanisms such as regulation of the gene expression, 
miRNA targeting, truncated proteins generation and others, thus favouring 
(stochastic) tumour cell heterogeneity and neoplastic predisposition. 
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METHODS 
 
Cell culture 
E14 mouse Embryonic Stem Cells (ESCs) were cultured in high-glucose 
DMEM (Invitrogen) supplemented with 15% FBS (Millipore), 0.1 mM 
nonessential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 0.1 
mM 2-mercaptoethanol, 1500 U/ml LIF (Millipore), 25 U/ml penicillin, and 25 
μg/ml streptomycin. The cells were mycoplasma free.  
Generation of Dnmt3b-/- ESCs was performed using TALEN technology. Cells 
were transfected with the two TALEN constructs targeting Exon 17 of murine 
Dnmt3b (corresponding to the start of the catalytic domain) and after 16 hours 
were seeded as a single cell. After ten days, clones were screened by 
western blot analysis. Positive clones were analysed by genomic sequencing. 
For half-life measurements and RNA Pol II elongation inhibition, WT and 
Dnmt3b-/- ESCs were treated with DRB at the concentration of 75 µM for the 
indicated times. 
 
Protein extraction and Western blotting 
For total cell extracts, cells were resuspended in F-buffer (10mM Tris-HCl pH 
7.0, 50mM NaCl, 30mM Na-pyrophosphate, 50mM NaF, 1% Triton X-100, 
anti-proteases) and sonicated for 3 pulses. Extracts were quantified using 
BCA assay (Pierce) and were run on SDS-polyacrylamide gels at different 
percentages, transferred to nitrocellulose membranes and incubated with 
specific primary antibodies overnight. 
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Nuclear proteins extract were performed as described in41. Briefly, cells were 
harvested in PBS 1x and resuspended in Isotonic Buffer (20mM HEPES pH 
7.5, 100mM NaCl, 250mM Sucrose, 5mM MgCl2, 5μM ZnCl2). Successively, 
cells were resuspended in isotonic buffer supplemented with 1% NP-40 to 
isolate nuclei. The isolated nuclei were resuspended in Digestion Buffer 
(50mM Tris-HCl pH 8.0, 100mM NaCl, 250mM Sucrose, 0.5mM MgCl2, 5mM 
CaCl2, 5μM ZnCl2) and treated with Microccocal Nuclease (NEB) at 30°C for 
10 min. 
 
Immunoprecipitation  
Nuclear proteins from about 10 x 106 cells were incubated with 3 g of 
specific antibody overnight at 4° C. Immunocomplexes were incubated with 
protein-G- conjugated magnetic beads (DYNAL, Invitrogen) for 2 hours at 4° 
C. Samples were washed four times with digestion buffer supplemented with 
0.1% NP-40 at RT. Proteins were eluted by incubating with 0.4M NaCl TE 
buffer for 30 min and were analysed by western blotting. 
 
DNA construct and shRNA  
Custom shRNAs against SetD2, Dis3 and Rrp6 were constructed using the 
TRC hairpin design tool (http://www.broadinstitute.org/rnai/public/seq/search), 
and designed to target the 3’-UTR. shRNAs with more than 14 consecutive 
matches to non-target transcripts were avoided. Hairpins were cloned into 
pLKO.1 vector (Addgene: 10878) and each construct was verified by 
sequencing. Dnmt3b construct was obtained by PCR amplification and cloned 
into pEF6/V5-His vector (Invitrogen). The Dnmt3b V725G, S277P, and VW-
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RR, constructs were generated by introducing a site-specific mutation in the 
DNA sequence corresponding to Val725 to mutate it into a Glycine, or Ser277 
to mutate in Prolin, or Val236Trp237 to mutate in Arg-Arg, using QuickChange 
XL Site-Directed Mutagenesis Kit (Agilent Technologies).  
 
Transfections 
Transfections of mouse ESCs were performed using Lipofectamine™ 2000 
Transfection Reagent in according to manufacturer’s protocol using equal 
amounts of each plasmid in multiple transfections.  For the SetD2 knockdown, 
cells were transfected with 5 µg of the specific shRNA construct, and 
maintained in medium with puromycin selection (1µg/ml) for 48h. 
 
Chromatin Immunoprecipitation assay 
To investigate the distribution of the endogenous Dnmt3b we tested different 
antibodies and found one that was able to immunoprecipitate the endogenous 
Dnmt3b cross-linked to chromatin, which showed no background signal in 
Dnmt3b-/- (Extended Data Fig. 1g-i). The ChIP-seq data were validated by 
ChIP-qPCR, using several biological replicates, on target genomic regions 
and by not cross-linked co-immunoprecipitation experiments between Dnmt3b 
and H3K36me3 in WT or Dnmt3b-/- ESCs (Extended Data Fig.1o, p). For 
Dnmt3b ChIP-seq, approximately 2 x 107 cells were cross-linked by addition 
of formaldehyde to 1% for 10 min at RT, quenched with 0.125 M glycine for 5 
min at RT, and then washed twice with cold PBS. The cells were resuspended 
in Lysis Buffer 1 (50 mM Hepes-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 
10% Glycerol, 0.5% NP-40, 0.25% Triton X-100 and protease inhibitor) to 
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disrupt the cell membrane and in Lysis Buffer 2 (10 mM Tris-HCl pH 8.0, 200 
mM NaCl, 1 mM EDTA, 0.5 mM EGTA and protease inhibitor) to isolate 
nuclei. The isolated nuclei were then resuspended in SDS ChIP Buffer (20 
mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS and protease inhibitors). 
Extracts were sonicated using the BioruptorH Twin (Diagenode) for 2 runs of 
10 cycles [30 sec ‘‘ON’’, 30 sec ‘‘OFF’’] at high power setting. Cell lysate was 
centrifuged at 12,000 g for 10 min at 4°C. The supernatant was diluted with 
ChIP Dilution Buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% 
Triton) before immunoprecipitation step. Magnetic beads (Dynabeads® Rat 
Anti-Mouse IgM for anti-PolII-phospho-S5, Dynabeads®Protein G for all the 
other ChIPs, Life Technologies) were saturated with PBS/1% BSA and the 
samples were incubated with 2 µg of antibody overnight at 4°C on a rotator.  
Next day samples were incubated with saturated beads for two hours at 4°C 
on a rotator. Successively immunoprecipitated complexes were washed five 
times with RIPA buffer (50 mM Hepes-KOH pH7.6, 500 mM LiCl, 1 mM 
EDTA, 1% NP-40, 0,7% Na-Deoxycholate) at 4°C for 5 min each on a rotator. 
For other ChIP-seq, ChIP-seq was performed as described42. Elution Buffer 
was added and incubated at 65°C for 15 min. The decrosslinking was 
performed at 65°C overnight. Decrosslinked DNA was purified using QiaQuick 
PCR Purification Kit (Quiagen) according to the manufacture’s instruction 
MeDIP was performed using MeDIP kit (Active Motif), according to 
manufacturer’s protocol. 
DNA was analysed by quantitative real-time PCR by using SYBR GreenER kit 
(Invitrogen). All experiment values were normalized to input. The data shown 
represent triplicate real-time quantitative PCR measurements of the 
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immunoprecipitated DNA. The data are expressed as (%) 1/100 of the DNA 
inputs. Error bars represent standard deviation determined from triplicate 
experiments. Oligonucleotide sequences are reported in TableS1. 
 
DNA extraction and dot-blot analysis 
Genomic DNA was extracted from cells using DNeasy Blood and Tissue kit 
(Qiagen). For dot-blot analysis, extracted genomic DNA was sonicated using 
the BioruptorH Twin (Diagenode) for 2 runs of 10 cycles [30 sec ‘‘ON’’, 30 sec 
‘‘OFF’’] at high power setting, in order to obtain 300 bp fragments, denatured 
with 0.4 M NaOH and incubated for 10 min at 95°C prior to being spotted onto 
HybondTM-N+ (GE Healthcare). Membranes were saturated with 5% milk and 
incubated with the specific antibodies overnight. 
 
ChIP-seq library preparation 
Approximately 10 ng of purified ChIP DNA were end-repaired, dA-tailed, and 
adapter-ligated using the NEBNext ChIP-seq Library Prep Master Mix Set 
(NEB), following manufacturer instructions. 
 
Whole genome bisulfite-seq library preparation 
For whole-genome Bisulfite-Seq library preparation, 2.5 g of ESCs genomic 
DNA, were spiked-in with 1ng of Escherichia coli genomic DNA, and sheared 
using a Bioruptor® Twin sonicator (Diagenode) for 3 runs of 10 cycles [30 sec 
“ON,” 30 sec “OFF”] at high power setting. Fragmented/digested DNA was 
then end-repaired, dA-tailed, and ligated to methylated adapters, using the 
Illumina TruSeq DNA Sample Prep Kit, following manufacturer instructions. 
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DNA was loaded on EGel Size select 2% agarose pre-cast gel (Invitrogen), 
and a fraction corresponding to fragments ranging from 180bp to 350bp was 
recovered. Purified DNA was then subjected to bisulfite conversion using the 
EpiTect Bisulfite Kit (Qiagen). Bisulfite-converted DNA was finally enriched by 
15 cycles of PCR using Pfu Turbo Cx HotStart Taq (Agilent). 
 
RNA extraction and RT-PCR analysis 
Total RNA was extracted as previously described43 by using TRIzol reagent 
(Invitrogen). Real-time PCR was performed using the SuperScript III Platinum 
One-Step Quantitative RT-PCR System (Invitrogen) following the 
manufacturer’s instructions. 
 
RNA-seq library preparation 
Ribo- RNA-seq library preparation was performed as described44. Briefly, 2.5 
µg of total RNA were depleted of ribosomal RNA using the RiboMinus 
Eukaryote System v2 kit (Invitrogen), following manufacturer instructions. 
Ribo- RNA was resuspended in 17 l of EFP buffer (Illumina), heated to 94°C 
for 8 min, and used as input for First Strand synthesis, using the TruSeq RNA 
Sample Prep kit, following manufacturer instructions. PolyA RNA-seq library 
was performed by using the TruSeq RNA Sample Prep kit, following 
manufacturer instructions. 
 
CAPIP-seq immunoprecipitation and library preparation 
For immunoprecipitation of mRNA for CAP-Seq experiments, 30 µg of total 
RNA were fragmented by alkaline hydrolysis in ~200nt fragments and 
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incubated with 5 µg of mouse anti-CAP antibody (Anti-m3G-cap, m7g-cap, 
Clone H20, Millipore MABE419) (or IgG) overnight at 4°C in 0.5 ml of IP 
Buffer (10mM Tris-HCl pH 7.5; 150mM NaCl; 0,1% Triton X-100) 
supplemented with 50 U/ml RNaseOUT (Invitrogen), 50 U/ml SuperaseIN 
(Invitrogen), and 50 U/ml RNase Inhibitor (Ambion).  25 µl of Dynabeads 
Protein G (Invitrogen) were saturated overnight at 4°C in IP Buffer 
supplemented with 150 µg of Sonicated Salmon Sperm DNA (Qiagen). 
Following incubation, beads were washed two times in IP Buffer and 
incubated with the preformed RNA-antibody complexes at 4°C. After 3hrs, 
beads were washed 4 times with IP Buffer. Specific elution of recovered 
fragments were obtained by incubation of beads with 100 µl Elution Buffer 
(5mM Tris pH7.5; 1mM EDTA; 0.05% SDS; 0.3 mg/ml Proteinase K) for 1h 30 
min at 50°C. Fragments were then purified by addition of 1ml of TRIzol 
reagent (Invitrogen), and subjected to random-primed reverse transcription 
using the SuperScript III Reverse Trancriptase (Invitrogen) at 50°C for 1 h. 
Resulting cDNAs were then used as input for the TruSeq RNA Sample Prep 
kit (Illumina), starting from the “Second Strand Synthesis” step, to produce the 
sequencing library, following manufacturer instruction. 
 
DECAP-seq library preparation 
To map the transcriptional start sites at single-base resolution we used an 
enzymatic-based approach by the use of the RNA 5' Pyrophosphohydrolase 
(RppH) enzyme to decap eukaryotic mRNAs21. We validated the specificity of 
this technique in a pilot experiment by comparing RppH treated RNA versus 
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untreated or T4 Polynucleotide Kinase (PNK) treated RNA (Extended Data 
Fig. 6a-e).  
When required the total RNA was depleted from small nuclear RNAs 
(snRNAs) by using the following protocol. 5 µg of Total RNA was 
resuspended in snRNA-depletion buffer (20mM HEPES pH 7.5, 80mM KCl, 
1 mM DTT), 1 l RNase Inhibitor (Ambion), 2 µM oligo mix (designed against 
snRNAs sequences, primers sequences in TABLE 1) in a final volume of 
50 l, heated to 70°C for 5 min and immediately put in ice. After that it was 
added 25 l snRNA-depletion buffer 2x (40mM HEPES pH 7.5, 160mM KCl, 
10 mM MgCl2, 2 mM DTT), supplemented with 1 l RNase Inhibitor (Ambion) 
and 1 l of RnNAse H (NEB) to a final volume of 100 l. Incubated for 30 min 
at 37°C. snRNA-depleted RNA were purified by RNA Clean and 
Concentration kit (Zymo Research) and DNAseI digestion was performed 
following manufacturer instructions. snRNA-depleted RNAs were further 
depleted from ribosomal RNA by using the RiboMinus Eukaryote System v2 
kit (Invitrogen).  
The RNA obtained from previous depletions (or polyA+ RNA enriched using 
The NEBNext Poly(A) mRNA Magnetic Isolation Module kit (NEB), following 
manufacturer instructions) was chemically fragmented by using First Strand 
buffer of the SuperScript® II Reverse Transcriptase (Invitrogen). The 
fragmented RNA was Dephosphorylated of natural 5’ and fragmentation-
derived 3’ phosphate by using Antarctic Phosphatase (AP, NEB). 
Dephosphorylated RNA was then treated with RNA 5´ Pyrophosphohydrolase 
(RppH, NEB) in 1X Thermopol buffer (NEB) (for decapping and 
pyrophosphate removal from the 5´ end of RNA to leave a 5´ monophosphate 
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RNA). For positive and negative control, the dephosphorylated RNA was 
treated with the T4 Polynucleotide Kinase (PNK, NEB) (for 5’ phosphorylation 
of all RNA fragments) or was performed without adding the enzyme. 5’ RNA 
adapter ligation was carried out by using the TruSeq Small RNA Sample 
Preparation Kit (Illumina). Reverse transcription was performed with 
SuperScript III enzyme (Invitrogen) and Illumina 3' Adapter Rev-Comp 
Random Hexamers (RC3N6). The RNA was size selected on TBE-Urea 10% 
PAGE gel and PCR amplification was carried out by using the TruSeq Small 
RNA Sample Preparation Kit (Illumina). 
 
ART-seq library preparation 
Ribosome profiling was performed using the ARTseq/TruSeq Ribo Profile 
(Illumina), with minor changes to the manufacturer protocol. Briefly, ~30x106 
cells were treated with 0.1μg/μl final Cycloheximide for 5 min at 37°C. Cells 
were then washed twice and harvested with ice-cold PBS (supplemented with 
0.1 µg/μl final Cycloheximide). Cells were lysed in 1ml of Mammalian Lysis 
Buffer (supplemented with 0.5 % final concentration of NP-40) at 4°C for 10 
min on a rotator. The lysate was then treated with 50 U of ART-seq Nuclease 
for 45 min at 25°C, with moderate shaking. 400 μl of the digested lysate were 
then layered on the top of a 2.5 ml sucrose cushion, and centrifuged at 
265,000 x g for 5 h at 4°C. After completely removing the supernatant, the 
pellet was resuspended in 100μl nuclease-free water, and purified on RNA 
Clean & Concentrator™-5 columns (Zymo Research). 5 μg of the recovered 
monosomes RNA was then subjected to 2 consecutive rounds of rRNA 
depletion using the Ribo-Zero™ Gold Kit (Human/Mouse/Rat, Epicentre), and 
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then run on a 10% TBE-Urea PAGE gel for 25 min at 200 V. A gel slice 
corresponding to 28-30 nt was then cut, crushed, and RNA was recovered by 
passive diffusion at 4°C for 16 h.  The eluted RNA fragments were then end-
repaired, ligated to the 3’ adapter, and reverse transcribed. The cDNA was 
run on 10 % TBE-Urea PAGE gel for 30 min at 180 V, and a gel slice 
corresponding to fragments of ~70-80 nt was cut, crushed, and cDNA was 
recovered by passive diffusion at 37°C for 16h with vigorous shaking. The 
eluted cDNA was then subjected to circularization, and the final library was 
obtained by 10 cycles of PCR. The final library was inspected on the 
Fragment Analyzer™ (Advanced Analytical), revealing a single sharp peak 
around 150 bp. 
 
Reads mapping and data analysis 
Samples were sequenced on the HiScanSQ or Next500 platforms (Illumina). 
All of the analysed datasets, were mapped to a recently published variant of 
the mm9 genome assembly, that includes single nucleotide variants from E14 
ESCs45. Prior mapping, sequencing reads were trimmed from low quality 
score basis and clipped from the adapter sequence by using FASTX toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/). For RNA-seq data analysis, reads 
were mapped using TopHat v2.0.646 and mRNA quantification was performed 
using Cuffdiff v2.0.247. For ChIP-seq data analysis, reads were mapped 
Bowtie version 0.12.748, reporting only unique hits with up to two mismatches 
(parameters: -m 1 –v 2). For Bisulfite-seq data analysis, reads were mapped 
using BSMAP v2.7449. Unmapped reads from the first mapping round were 
trimmed by 10nt at their 5’-end, and 15nt at their 3’-end using fastx_trimmer 
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tool from the FASTX Toolkit, and subjected to a second round of mapping.  
Reads failing this second mapping round were mapped to the Escherichia coli 
str. K-12 substr. DH10B genome (NCBI Accession: NC_010473), in order to 
estimate bisulfite conversion efficiency.  
 
RNA-seq analysis 
RNA-seq correlation analyses were performed by using Pearson correlation 
coefficient and by plotting RPKM value calculated on RefFlat gene annotation. 
Intragenic transcription initiation analysis was performed on a non-redundant 
gene annotation built starting from the RefFlat annotation, by keeping only the 
longest isoform for each gene, with at least 1 RPKM of expression and at 
least 5 exons. RPKM on each exon was calculated by counting reads falling in 
the exon (normalizing on the exon length in kb and on the total mapped reads 
of the experiment in millions) using custom script and then the ratio was 
calculated as the Log2 fold-change of second, third and last exons RPKM 
over the first exon RPKM for each gene. For intermediate/first exons ratio, 
averages of the RPKM value of all the other exons (from 4th to penultimate) 
were used. Alternative promoter analysis was performed on a non-redundant 
gene annotation built starting from the RefFlat annotation by keeping only the 
genes having at least 2 isoforms transcribed from known different promoters. 
RPKM of the first exon of the isoforms transcribed from 1st or 2nd alternative 
promoter and, for those having, from the 3rd, 4th or all the others (from 5th to 
12th) alternative promoters, was calculated by custom script. Log2 ratio 
between the first exons transcribed from the 1st over the 2nd promoter was 
plotted by using heatscatter function (on R) and correlation was calculated by 
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using Pearson coefficient. Alternative promoter analysis was calculated on the 
same reference as above. Log2 ratio was calculated as RPKM value of the 
first exon transcribed from each classes of different alternative promoter over 
the RPKM of the whole transcript, in order to normalize differentially 
expressed genes in WT and Dnmt3b-/- cells. 
 
DECAP-seq analysis 
For DECAP-seq only intragenic mapped reads were used for further analysis. 
We used a RefSeq-based genic reference containing only the annotated 
longest isoforms and deprived from all the genes overlapping other genes or 
ncRNAs on the same strand. Since DECAP-seq is a single base resolution 
technique and the first base of the sequenced reads corresponds to the base 
having the cap signal, only the first position of the mapped read was used to 
calculate a count per million of mapped reads (RPM). All the analyses were 
performed on the genes belonging to the q3 or q4 quartiles of expression.  
Venn diagram overlap is calculated at single-base resolution.  Logo analysis 
of the sequence enrichment was performed by using WebLogo 
(http://weblogo.berkeley.edu/). Motif discovery was performed by using 
HOMER Motif Analysis (http://homer.salk.edu/homer/motif/). 
 
CAPIP-seq analysis 
For CAPIP-seq only intragenic mapped reads were used for further analysis. 
RPKM of each genomic feature were calculated as described above by using 
custom script. Enrichment was calculated as the Log2 fold change of RPKM 
value from CAP immunoprecipitated samples over the RPKM from Input 
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samples for each genomic feature. As for DECAP-seq, Intragenic CAPIP-seq 
signal ratio between wt and Dnmt3b-/- cells was calculated as the fold change 
of the intragenic enrichment (from 2kb downstream TSS to TES) in WT over 
Dnmt3b-/- cells. Ratio gene-body/TSS was defined as the Log2 fold change of 
gene-body enrichment (derived from intronic and intermediate exonic regions) 
over the enrichment calculated on the first 200nt of the transcripts. All the 
analyses were performed on the genes belonging to the q3 or q4 quartiles of 
expression. 
 
Half-life analysis 
PolyA enriched RNA-seq analyses were performed from RNA derived from 
DRB-treated wt and Dnmt3b-/- ESCs. For half-life calculation, gene 
quantifications performed with CuffDiff (see above) were normalized on the 
average of the top ten genes showing less degradation rate following DRB 
treatment having at least 10 RPKM in ESCs. Degradation rate has been 
defined as the ratio of RPKM value of the sample at time 0h of DRB treatment 
over the average RPKM value of the samples treated for 3, 6 and 12 hours 
with DRB. The top ten genes are Tmsb10, Mt1, Mt2, Rps14, Rplp2, 
4930412F15Rik, Rpl38, Rplp1, Tomm7 and Cox6a1. Only genes having 
RPKM > 1 were used for further analysis and a constant of 0.1 pseudo-RPKM 
was introduced to reduce sampling noise. Half-life (t1/2) was calculated by 
using the following formula50:  
 t1/2  = 
ln2
kdecay
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where kdecay is the decay rate constant obtained by fitting data (gene RPKM 
value for each time points) with an exponential function. Half-life on introns 
was measured as calculated for mature mRNAs, but gene quantification 
(RPKM) was performed counting the reads on introns and normalizing for 
introns length (kb) and for the number of total intragenic mapped reads 
(milions). For introns and exons quantification, reads were treated as above 
(see RNA-seq analysis). 
 
Ribosome profiling analysis (ART-seq) 
Analysis of ART-seq experiments were performed as previously described31. 
Differently from the other sequencing data, for ribosome profiling, only adapter 
containing reads were used in order to avoid total RNA contamination. Reads 
were clipped from adapters and mapped on rRNAs and tRNAs. Only reads 
not mapping on rRNA/tRNA genes were used for downstream analysis. 
Quantification (RPKM) of the reads derived from different transcript parts or 
genomic features was performed as described above. 
 
ChIP-seq and WGBS analysis 
Following mapping, reads with the same start mapping coordinates were 
collapsed using custom Perl scripts, and peak calling was performed using 
MACS version 1.4.151. 
ChIP-seq signal Log2 enrichment was calculated as previously described10, 
with some modifications. Briefly, the mouse genome was partitioned into 500 
bp bins. Bins overlapping with satellite repeats and with an insufficient 
coverage in WGBS (less than 50% of all CpGs covered at least 10x) were 
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removed resulting in 2,708,724 bins. Signal enrichment was calculated as the 
Log2 of ChIP-seq/Input RPKM. These whole-genome Log2 enrichment values 
were used for clustering, correlation, boxplots and scatterplots analysis by 
using custom scripts. For genomic binning by H3K36me3, the above bins 
were divided in ten equal-size groups rank-ordered by their Log2 enrichment 
for H3K36me3.  
Heatmap representations of ChIP-seq peaks and plots were performed with 
respect to annotated RefSeq genes, sorted by their expression level, 
according to RNA-seq data. Plots of Dnmt3b and H3K36me3 distribution on 
genes clustered in quartiles of expression revealing an almost identical 
distribution for both features.  
For the analysis of Dnmt3b intragenic binding in Setd2 KD ESCs and Dnmt3b-
reexpressing Dnmt3b-/- ESCs, a non-redundant gene annotation was built 
starting from the RefFlat annotation, by keeping only the longest isoform for 
each gene. After calling H3K36me3 peaks in WT ESCs using MACS 1.4.1 
(parameters: -p 1e-8 --nolambda), the genes from the RefFlat annotation that 
overlap an H3K36me3 peak were marked as H3K36me3-positive, while 
genes lacking any overlap were marked as H3K36me3-negative. For each 
gene in the two datasets, the normalized Dnmt3b signal  (RPKM) in control 
and treated ESCs was calculated as: 
  
where n is the number of Dnmt3b reads overlapping gene’s coordinates, TSS 
and TES are respectively the start and end coordinate of the gene annotation, 
and N is the total number of mapped reads in the ChIP-seq experiment. P-
RPKM = 109 ´  
n
(TES -TSS)´N
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values were calculated using a one-tailed paired Wilcoxon rank sum test 
statistics. 
Methylation calling was performed using the methratio.py script provided with 
the BSMAP tool and comparative analyses were performed by using only 
CpG covered at least 5x in both wt and Dnmt3b-/- cells.  
Heatmaps and comparative analysis were performed using custom Perl 
scripts. Datasets used for comparative analysis were obtained from Gene 
Expression Omnibus by downloading the following datasets GSE12241, 
GSE11172, GSE31039, GSE44642, GSE44566, GSE55660, GSE57413, 
GSE44566). 
 
Antibodies  
Antibodies were purchased from Abcam (anti-Dnmt3b; anti-H3K36me3; anti-
single strand DNA; anti-H3 pan; anti-Tbp; anti-TIIb), from Imgenex (anti-
Dnmt3a; anti-Dnmt3b; anti-Dnmt1), from Diagenode (anti-5-methylcytidine), 
from Millipore (anti-H3K27me3; Anti-m3G-cap, m7G-cap; anti-Elk1), from 
Upstate (anti-H3K4me3), from Covance (RNA PolII-phosphoSer5), from 
SantaCruz (pan RNA PolII, anti-Sp1; anti-Elf1), from Upstate (anti-H3K4me3; 
anti-H3ac). Antibody anti-Dnmt3L was kindly provided from Dr. S. Yamanaka 
(Kyoto University, Japan). 
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Figure Legends 
 
Figure 1 | Dnmt3b colocalises with H3K36me3 on the gene body and its 
loss reduces gene body DNA methylation. a, Binding enrichment of control 
IgG and endogenous Dnmt3b in WT and Dnmt3b-/- ESCs on the specified 
genomic features. b, Box plot of the endogenous Dnmt3b in ESCs on the 
introns and exons partitioned in quartiles on the basis of the expression level 
(q4 = upper quartile, most expressed genes). c, Heatmap plots of Dnmt3b and 
H3K36me3 distribution on genes (see methods). d, Violin plot of the 
methylation level of all CpGs by WGBS. e, Genomic 500bp-bins divided in 
deciles depending on their H3K36me3 enrichment.  
 
 
Figure 2 | Dnmt3b knockout increases intragenic RNA Pol II spurious 
entry and transcription initiation events on gene body. a, Box plot of the 
ratio between normalized RNA-seq read counts (RPKM) in WT and Dnmt3b-/- 
ESCs. Significance is given by Wilcoxon Rank Sum test statistics. b, Pie-chart 
showing the percentage of transcripts having (intermediate/first exon ratio in 
Dnmt3b-/- vs. intermediate/first exon ratio in WT ESCs) Log2 fold-change as 
indicated c, Plots of the pan (left panel) or phospho-Ser5 (right panel) RNA 
pol II distribution in WT and Dnmt3b-/- ESCs treated (or not, left panel) with 
DRB to inhibit RNA Pol II elongation. d, Binding enrichment of the pan (upper 
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panel) or phospho-Ser5 (bottom panel) RNA pol II in WT and Dnmt3b-/- ESCs 
treated (or not, only pan RNA Pol II) with DRB on the indicated genic features. 
 
Figure 3 | Dnmt3b is required to maintain transcription initiation fidelity. 
a, b, Total TSSs distribution along genes in Dnmt3b-/- compared with WT 
ESCs.  c, Venn diagram of intragenic TSSs having DECAP-seq signal > 6 
RPM. Overlap is calculated at single-base resolution. d, Pie-charts of the 
DECAP-seq reads distribution on TSSs > 6 RPM in WT and Dnmt3b-/-  cells. 
e, Box plot distribution of the IgG, Dnmt3b, and H3K36me3 ChIP-seq signal 
enrichment as well as of the DNA methylation ratio between Dnmt3b-/- and 
WT ESCs (from WGBS) and nucleosome occupancy on the novel identified 
TSSs.   f, Sequence logo for genomic region sequences of the TSSs identified 
by DECAP-seq experiments in Dnmt3b-/- and WT ESCs. g, h, Histogram plot 
of observed over expected ratio showing a specific enrichment in CpG 
dinucleotide in a region around 25nt of Dnmt3b-/- specific TSSs and a 
significant enrichment for CpG containing motifs in Dnmt3b-/- ESCs specific 
intragenic TSSs. i, Genomic view of the Fn1 and Phb2 genes showing 
intragenic transcription initiation events. Pie-charts indicate the DECAP-seq 
reads distribution in Dnmt3b-/- and WT ESCs. Bottom panel, schematic 
representation of CpG localization and putative transcription factors binding 
elements. Significance is given by Wilcoxon Rank Sum in panels b and e and 
by chi-square test statistics in panel g.   
 
 
Figure 4 | H3K36me3-dependent maintaining of transcription initiation 
fidelity is mediated by Dnmt3b through its DNA methylation activity. 
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a, Western blotting analysis of control or SetD2 knockdowns in WT and 
Dnmt3b-/- ESCs. b, Box-plot of normalized Dnmt3b ChIP-seq read counts 
(RPKM) in control or SetD2 knockdown WT cells on H3K36me3 negative and 
positive genes. c, Dnmt3b distribution on genes in control or SetD2 
knockdown cells. d, Box plot of the ratio between normalized RNA-seq RPKM 
in WT and Dnmt3b-/- control or SetD2 knockdown ESCs. e, Pie-charts 
showing the percentage of transcripts having (intermediate/first exon ratio in 
the indicated treatments vs. intermediate/first exon ratio in WT control 
knockdown ESCs). f, Western blot of Dnmt3b-/- ESCs transfected with mock, 
Dnmt3b (WT) or inactive Dnmt3b (V725G). g, Box-plot of normalized Dnmt3b 
ChIP-seq RPKM in Dnmt3b-/- ESCs transfected as indicated. h, Dnmt3b 
distribution on genes in Dnmt3b-/- ESCs transfected as indicated. i, Box plot of 
the ratio between normalized RNA-seq RPKM transfected as indicated. j, Pie-
chart showing the percentage of transcripts having (intermediate/first exon 
ratio in Dnmt3b (WT or mutant) expressing Dnmt3b-/- ESCs vs. 
intermediate/first exon ratio in mock Dnmt3b-/- ESCs) Log2 fold-change (FC) 
as indicated. Significance is given by Wilcoxon Rank Sum in panels b, d. g, 
and e.     
 
Figure 5 | Transcripts produced from intragenic cryptic starting sites are 
polyadenylated, stable and ribosome-associated RNAs. 
a, Box plot of the ratio between normalized polyA RNA-seq RPKM in WT and 
Dnmt3b-/- ESCs.   b, Pie-chart showing the percentage of transcripts having 
(intermediate/first exon ratio in Dnmt3b-/- vs. intermediate/first exon ratio in 
WT ESCs) Log2 fold-change as indicated. c, Venn diagram of the Dnmt3b-/- 
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specific intragenic TSSs (RPM > 6) in the indicated RNA compartments. d, 
Box plot of the normalized DECAP-seq RPM on the Dnmt3b-/- specific 
intragenic TSSs in the indicated RNA compartments.   e, Pie-chart of the 
DECAP-seq reads distribution. f, Box plot of the RPKM counts on introns in 
time-course cells (WT and Dnmt3b-/-) treated with DRB.  g, Box plot of the 
ratio between normalized polyA+ RNA-seq RPKM in WT and Dnmt3b-/- ESCs 
treated 12h with DRB. h, Pie-chart showing the percentage of transcripts 
having (intermediate/first exon ratio in Dnmt3b-/- vs. intermediate/first exon 
ratio in WT ESCs) Log2 fold-as indicated in cells treated 12h with DRB. i, Box 
plot of the normalized ART-seq RPKMon the indicated RNA regions. j, Box 
plot of the normalized ART-seq RPKM on the indicated classes of introns 
divided in quartiles in according to the belonged gene expression. 
Significance is given by Wilcoxon Rank Sum in panels a, d, g f, i, and j.  
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Extended Data Figures 
 
Extended Data Figure 1: Generation of Dnmt3b-/- and mapping of the 
endogenous Dnmt3b in ESCs. 
Dnmt3b-/- ESC clones (B126 and B77) showed normal cell growth and 
alkaline phosphatase (AP) staining as well as impaired silencing, by promoter 
DNA methylation of Nanog expression during the differentiation into 
embryonic bodies (EBs) with respect to the WT cell line, thus indicating the 
bona fide nature of the transgenic cell lines. a, Scheme of the region of the 
Dnmt3b gene targeted by TALEN zinc-fingers, and representative sequences 
on the two alleles of two Dnmt3b-/- clones, compared to WT (KO #1 = B77; KO 
#2 = B126). b, Western blot analysis of Dnmt3b protein in the two Dnmt3b-/- 
clones compared to WT. Dnmt1 and Dnmt3a2 levels are not affected by loss 
of Dnmt3b. Actin is used as loading control. Interestingly, also the mRNA level 
(data not shown) of the Dnmt3b gene is almost completely lost in Dnmt3b-/- 
cells.  c, Growth curve of WT and Dnmt3b-/- ESCs in a 3-days’ time course. d, 
Alkaline phosphatase staining of WT and Dnmt3b-/- ESC colonies. e, RT-
qPCR of Nanog levels in embryoid bodies (EBs) derived from Dnmt3b-/- 
clones, compared to WT ESCs, and EBs. Error bars represent the standard 
deviation of at least 3 independent experiments. f, Sanger sequencing of 
bisulfite-treated genomic DNA from WT ESCs and EBs, and Dnmt3b-/- ESCs-
derived EBs, at the region of the Nanog promoter previously shown to be 
target of Dnmt3b-mediated methylation upon differentiation52.  g, Histogram 
showing the quantity of the DNA recovered in ChIP experiments performed 
with different antibodies directed against Dnmt3b protein. h, Western blot 
analysis of Dnmt3b protein in WT and Dnmt3b-/- ESCs. Actin was used as 
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loading control. i, Histogram showing the quantity (ng) of the DNA recovered 
in ChIP experiments performed with anti-Dnmt3b antibody (Ab122932) in WT 
and Dnmt3b-/- ESC. j, Genomic views of the mapped reads from different 
ChIP-seq datasets in ESCs. IgG and Dnmt3b ChIP-seq and WGBS are from 
the present work, bio-Dnmt3b from GSE57413, MeDIP-seq from GSE44644, 
GLIB-seq from GSE44566, histone modifications from GSE12241. k, (Left) 
Heatmap representations of Dnmt3b binding and relevant histone 
modifications on a window of ±3kb centred on the TSS of RefSeq genes, 
sorted by their expression level, according to RNA-seq data. (Right) Plots of 
Dnmt3b binding and relevant histone modifications on a window of ±3kb 
centred on the TSS of RefSeq genes, clustered in the 4 quartiles of 
expression (q4 = upper quartile, the most expressed genes). l, m, Binding 
enrichment of IgG (in WT ESCs) as well as IgG and Dnmt3b (in Dnmt3b-/- 
ESCs) on the exons or introns partitioned in quartiles on the basis of the 
expression of the related gene. These figures represent control experiments 
for the Figure 1b. n, Hierarchical clustering of pairwise Pearson correlation of 
Dnmt3b, and third-party ChIP-seq datasets in ESCs, reveals a strong 
genome-wide association of Dnmt3b with H3K36me3 histone mark. 
o, Scatterplots comparing intragenic H3K36me3 and IgG/Dnmt3b 
enrichments (Log2) in WT and Dnmt3b-/- cells. r = Pearson correlation. 
p, qPCR of ChIP analysis of Dnmt3b on the indicated regions. A specific 
enrichment can be observed on gene body of active genes. Error bars 
represent the standard deviation of at least 3 independent experiments. 
Primers used are reported in Table S1. q, Immunoprecipitation experiment 
(using a different antibody for Dnmt3b, Ab2851) in ESCs reveals the 
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interaction of Dnmt3b with H3K36me3, but not H3K4me3, in agreement with 
ChIP-seq data. r, Violin plots of the methylation level of all CpGs covered in 
both WT and Dnmt3b-/- ESCs WGBS on the indicated genomic features. 
Significance is given by Wilcoxon Rank Sum test statistics. 
 
 
Extended Data Figure 2: Dnmt3b loss increases intragenic RNA 
transcription initiation. 
a, Scatter plots of the Log2 RPKM gene values in the indicated samples. r = 
Pearson correlation. b, Genomic views of the RNA-seq mapped reads from 
the indicated samples. c, Box plots of the ratio between normalized RNA-seq 
read counts (RPKM) for the second and the first exon (left-top), the third and 
the first exon (left-bottom), the average of the intermediate exons (from the 4th 
to penultimate) and the first exon (right-top), the last and the first exon (right-
bottom), in WT (rep #2) and Dnmt3b-/- (rep #2 and clone B77) ESCs. 
Significance is given by Wilcoxon Rank Sum test statistics. d, Pie-chart 
showing the percentage of transcripts having (intermediate/first exon ratio in 
Dnmt3b-/- (rep #2 and clone B77) vs. intermediate/first exon ratio in WT (rep 2) 
ESCs) Log2 fold-change > 1, < -1 or between -1 and 1. e, RT-qPCR analysis 
of Ints2, Nodal, Gabpa and XpoI transcripts by using primers targeting 
different exons to discriminate different isoforms in WT, Dnmt3b-/- (cl. B126) 
and Dnmt3b-/- (cl. B77) ESCs. All the PCR were normalized on -Actin and on 
the WT condition. Error bars represent the standard deviation of at least 3 
independent experiments. P-value was calculated against WT condition for 
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each experiment by using t-test. (** p-value < 0.001, * p-value < 0.01). 
Primers used are reported in TableS1. 
 
Extended Data Figure 3: Dnmt3b loss does not extensively affect 
alternative promoter activation. 
We investigate the activation or repression of alternative promoters on the 
subset of genes showing at least two annotated alternative promoters. On 
these genes, we measured the RPKM value of the first exon of all the 
isoforms transcribed from the first, second, third, fourth or 5-12th promoter in 
WT or Dnmt3b-/- cells. We observed that the Dnmt3b-/- cells showed a general 
trend to have genes with the first exon less expressed independently from the 
isoform, thus suggesting a non-global general activation of intragenic 
promoters. Analysis of the ratio of the expression between the 1st promoter 
and the 2nd downstream promoter identified 4 genes (on a total of 2563 
genes) with a reactivation of the intragenic promoter in Dnmt3b-/- cells. a, 
Scheme of the gene dataset used for alternative promoter analysis. The 
dataset is composed of total 2563 gene showing at least two annotated 
alternative promoters, including 713 genes having at least three, 195 genes at 
least four and other 189 genes with multiple alternative promoters (from 5 to 
max 12). b, RPKM value of the first exon of all the isoforms transcribed from 
the first, second, third, fourth or 5-12th promoter in WT or Dnmt3b-/- ESCs. 
Dnmt3b-/- cells showed a general trend to have genes with the first exon less 
expressed independently from the isoform, and none of putative intragenic 
promoters (from the 2nd to the 12th) showed general activation. c, Analysis of 
the ratio of the expression of the 1st promoter over the 2nd downstream 
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promoter displayed high correlation between replicates and WT or Dnmt3b-/- 
ESCs. Only 4 genes (on a total of 2563 genes) showed a reactivation of the 
intragenic promoter in Dnmt3b-/- ESCs. Further analysis of the ratio between 
RPKM of the first exon and of the whole transcript for each class of alternative 
promoters transcribed genes did not show any evidence for possible 
reactivation of any class of transcript isoforms derived from intragenic 
promoters. d, e, Analysis of the ratio of the RPKM value of the first exon over 
the whole transcript for each class of alternative promoters transcribed genes 
showed high correlation between WT and Dnmt3b-/- ESCs and did not reveal 
evidence for possible reactivation of any class of transcript isoforms derived 
from intragenic promoters. 
 
Extended Data Figure 4: Dnmt3b loss does not globally affect elongating 
RNA Pol II or H3K36me3 deposition on the gene bodies, but increases 
intragenic RNA Pol II spurious entry. 
a, Genomic views of the mapped reads from the indicated different ChIP-seq 
datasets in WT and Dnmt3b-/- ESCs normally cultured or treated with the RNA 
Pol II elongation inhibitor DRB. b, Hierarchical clustering of pairwise Pearson 
correlation of ChIP-seq experiments performed in this work, and third-party 
ChIP-seq datasets in ESCs. c, Heatmap representations of the indicated 
ChIP-seq (in WT and Dnmt3b-/- ESCs) peaks with respect to annotated 
RefSeq genes, sorted by their expression level, according to RNA-seq data. 
Each gene was extended by 3kb upstream of its TSS, and downstream of its 
TES. d, Plots of the H3K36me3 distribution in WT and Dnmt3b-/- ESCs. e, 
Binding enrichment of the H3K36me3 on intermediate exons and introns in 
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WT and Dnmt3b-/- ESCs. f, Binding enrichment of the indicated ChIP-seq 
experiments in WT and Dnmt3b-/- ESCs treated (or not) with DRB on the 
intermediate exons and introns subdivided in quartiles of expression. This 
result demonstrated that only not elongating RNA Pol II is enriched on the 
bodies of the most expressed genes (q3 and q4) in Dnmt3b-/- ESCs. 
Significance is given by Wilcoxon Rank Sum test statistics (** p-value < 2.2E-
16). g, Genomic views of the mapped reads from the ChIP-seq analyses for 
H3K4me3 and H3ac in WT and Dnmt3b-/- ESCs. h, Hierarchical clustering of 
pairwise Pearson correlation of ChIP-seq experiments performed in this work, 
compared with ENCODE ChIP-seq datasets. i, Heatmap representations of 
the indicated ChIP-seq (in WT and Dnmt3b-/- ESCs) peaks with respect to 
annotated RefSeq genes, sorted by their expression level, according to RNA-
seq data. Each gene was extended by 3kb upstream of its TSS, and 
downstream of its TES. j, Binding enrichment of the indicated ChIP-seq 
experiments in WT and Dnmt3b-/- ESCs on the first exons, intermediate exons 
and introns subdivided in quartiles of expression. This result demonstrated 
that H3K4me3 and H3ac distribution are enriched on the intermediate exons 
and introns of the most expressed genes of the Dnmt3b-/- ESCs. Significance 
is given by Wilcoxon Rank Sum test statistics. 
 
Extended Data Figure 5:  CAPIP-seq enrichment of the 5’ of the RNAs 
shows that Dnmt3b loss increases intragenic spurious transcription 
initiation. 
a, Schematic view of the CAPIP-seq protocol used. Total RNA is chemically 
fragmented and then subjected to immunoprecipitation by using specific anti-
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CAP antibody or control anti-IgG antibody. Eluted RNA (as well as 1/10 of the 
starting material for Input) is subjected to random primer reverse transcription. 
Library is then completed starting from second strand generation. b, Scatter 
plots of the Log2 RPKM of CAPIP-seq data (anti-CAP antibody) and Input in 
WT and Dnmt3b-/- ESCs. r = Pearson correlation. c, Hierarchical clustering of 
pairwise Pearson correlation of CAPIP-seq related sequencings in WT and 
Dnmt3b-/- ESCs. d, Genomic views of the total mapped reads from the 
indicated CAPIP-seq related sequencings. Enrichment of the CAP signal is 
present on the 5’ of the RNA as a peak of about 150bp broader with respect 
to the signal obtained by performing DECAP-seq. e, Plots of the CAPIP-seq 
mapped reads distribution in WT and Dnmt3b-/- ESCs with respect to 
annotated RefSeq genes, extended by 5kb upstream of its TSS, and 
downstream of its TES. f, Box-plots of the Log2 enrichment of the CAPIP-seq 
signal rep#2 (CAP immunoprecipitation signal over input in WT and Dnmt3b-/- 
ESCs on the indicated genic features. Significance is given by Wilcoxon Rank 
Sum test statistics. g. Further analysis showing the increase of CAP 
localization from intragenic regions of the RNA. Intragenic ratio is calculated 
as the Log2 ratio of cap signal gene-body enrichment in Dnmt3b-/- versus WT 
cells. The correlation between the two replicates is shown (r = Pearson 
correlation).  
 
Extended Data Figure 6: DECAP-seq method maps, at single base 
resolution, TSSs on the gene body in ESCs.  
a, Schematic representation of the workflow of the DECAP-seq technique that 
is based on the RNA 5´ Pyrophosphohydrolase (RppH) enzymatic activity that 
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in Thermopol buffer is able to mediate decapping and pyrophosphate removal 
from the 5´ end of RNA to leave a 5´ monophosphate RNA (5’-P). 5’-P RNA is 
then used for selective adapter ligation by T4 RNA ligase to the originally 
capped RNA fragments allowing single base resolution mapping of the RNA 
capping sites. Treating sample in the same way, but without RppH enzyme 
generates a negative control (to detect technical background). Positive control 
is generated by treating sample with T4 Polynucleotide Kinase (PNK) for 5’ 
phosphorylation of all RNA fragments. This method represents an affordable 
alternative to the use of the Tobacco Acid Pyrophosphatase (TAP) enzyme 
that has been used in several high-throughput techniques as GRO-seq, CAP-
seq, CIP-TAP53 because the EpiCentre Technologies (so far the only 
company producing commercial TAP) has discontinued TAP and all kits 
containing it. b, Total RNA fragmentation was verified by using Fragment 
Analyzer™ (Advanced Analytical). c, Final DECAP-seq libraries were 
inspected on Fragment Analyzer before gel size selection. RppH treated and 
untreated samples showed a double peak around 130bp corresponding to the 
dimers of adapter, but only the RppH treated sample showed a higher 
enrichment (in the red box) corresponding to the decapped RNA fragments. 
PNK treated sample displayed a large peak around 200 bp. d, Final DECAP-
seq libraries were quantified on Qubit (Invitrogen) after gel size selection and 
PCR enrichment. Library generated by treating RNA with RppH showed a 
fifty-fold higher concentration with respect to the library generated without 
RppH treatment (5 ng/µl vs. 0.1 ng/µl). e, Genomic views of the total DECAP-
seq mapped reads from the indicated treatment on a gene (Actb) on the Crick 
DNA strand (- strand) and a gene (Rpl5) on the Watson DNA strand (+ 
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strand). A pronounced sharp peak (red arrow) is present on the TSS only on 
the respective gene strand, thus reflecting both the cap- and strandness- 
specificity of the method. Unstranded RNA-seq is shown as reference 
example. f, Plot of total TSSs (identified by using DECAP-seq rep #2) 
distribution along genes in Dnmt3b-/- (blue line) compared with WT (red line) 
ESCs. g, Box plots showing the number of total TSS / gene on RefSeq 
annotated TSSs and on gene body in WT and Dnmt3b-/- ESCs. Significance is 
given by Wilcoxon Rank Sum test statistics. h, Histogram plot showing the 
average RPM of novel identified TSSs by DECAP-seq in both replicates of 
WT ESCs. i, j, Scatter plots of the Log2 RPM values on canonical annotated 
TSSs(±100bp) in both replicate of DECAP-seq samples in WT and Dnmt3b-/- 
ESCs. r = Pearson correlation. k, Venn diagrams of intragenic TSSs having 
DECAP-seq signal > 6 RPM showing the single-base resolution overlap 
between the DECAP-seq experiments replicates. Significance is given by the 
Hypergeometric Distribution test statistics. l, Venn diagram of intragenic TSSs 
having DECAP-seq signal > 6 RPM showing single-base resolution overlap 
between Dnmt3b-/- and WT ESCs (rep #2). m, Pie-charts of the DECAP-seq 
reads distribution on TSSs > 6 RPM in WT (on the left) and Dnmt3b-/- (on the 
right) cells (rep #2). In green are shown the novel TSSs that overlap with 
RefSeq annotated TSS, in yellow all the common TSSs distributed on gene 
body and in pink the sample-specific TSSs on gene body. n, Box-plot 
distribution of the enrichment of the CAPIP-seq and Pol II ChIP-seq signals 
calculated as the Log2 ratio in Dnmt3b-/- versus WT cells on the novel 
identified TSSs (in green those overlapping with RefSeq annotated TSSs and 
in pink those specifically found on gene bodies of Dnmt3b-/- ESCs) and on an 
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intragenic random dataset. Significance is given by Wilcoxon Rank Sum test 
statistics. o, Box-plot distribution of the ratio between downstream and 
upstream exon expression levels with respect to the novel identified intragenic 
TSSs or an intragenic random dataset in Dnmt3b-/- cells. The exon expression 
levels were calculated by counting the reads from the RNA-seq experiments 
in Dnmt3b-/- or WT cells. Significance is given by Wilcoxon Rank Sum test 
statistics. 
 
 
Extended Data Figure 7: DECAP-seq maps in Dnmt3b-/- ESCs the internal 
TSSs revealing their correlation with the binding of methylation 
sensitive transcription factors.  
a, Sequence binding logo of the indicated transcription factors. b, Schematic 
representation of CpG localization and putative transcription factors binding 
elements on the regions (±50bp) of some Dnmt3b-/- ESCs specific intragenic 
TSSs is shown. c, RT-qPCR analysis of CAPIP (top panel) and qPCR 
analysis of ChIP (middle panel) experiments on the indicated genomic regions 
in WT and Dnmt3b-/- ESCs. For CAPIP RT-qPCR the primers were designed 
downstream the novel identified TSSs. Bottom panel represents the fold 
difference of the ratio between downstream and upstream exon expression 
levels with respect to the novel identified intragenic TSSs. For TSSs falling on 
exon, the downstream or upstream part of the same exon was considered as 
downstream or upstream exon if longer than 200bp. P-value was calculated 
against WT condition by using t-test. (** p-value < 0.01; * p-value < 0.05; n.s. 
= not significant). d, Sanger bisulfite sequencing of WT and Dnmt3b-/- ESCs 
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on intragenic TSSs previously described. e, qPCR analysis of ChIP 
experiments on the indicated genomic regions. 
 
Extended Data Figure 8: SetD2 knockdown reduces H3K36me3 mark, 
Dnmt3b binding, intragenic DNA methylation, and spurious TSSs on the 
gene bodies. 
a, RT-qPCR of SetD2 knock-down in WT and Dnmt3b-/- ESCs, using two 
independent shRNAs. Error bars represent the standard deviation of at least 3 
independent experiments. b, Venn diagram showing genome-wide the 
number of H3K36me3 peaks in control and SetD2 knockdown ESCs. c, Plots 
of H3K36me3 distribution on genes in control and SetD2 knockdown cells 
show a decrease of H3K36me3 distribution on gene bodies of the SetD2 
silenced cells. d, Histograms of the percentage of Dnmt3b ChIP-seq peaks 
overlapping intronic, and exonic regions of genes clustered in quartiles of 
expression (q1-4) in control or SetD2 knockdown cells. P-value was 
calculated by using chi-squared test. (** p-value < 0.001). e, Genomic views 
of the mapped reads from H3K36me3 and Dnmt3b ChIP-seq datasets in 
control and two different SetD2 knockdowns ESCs. f, qPCR analysis of 
H3K36me3 and Dnmt3b ChIP experiments and MeDIP analysis in control and 
SetD2 knockdown cells for the indicated genomic regions. A specific loss of 
Dnmt3b and DNA methylation is observed only on gene body of active genes. 
Error bars represent the standard deviation of at least 3 independent 
experiments. P-value was calculated against WT condition for each 
experiment by using t-test. (** p-value < 0.001). Primers used are reported in 
TableS1. g, Scatter plots of the Log2 RPKM gene values in the indicated 
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samples. r = Pearson correlation. h, Genomic views of the RNA-seq mapped 
reads from the indicated samples. i, Plot of total TSSs (identified by using 
DECAP-seq) distribution along genes in SetD2 knockdown (yellow line) 
compared with control knockdown (red line) ESCs. j, Box plots showing the 
number of total TSS / gene on RefSeq annotated TSSs and on gene body in 
control and SetD2 knockdown ESCs. Significance is given by Wilcoxon Rank 
Sum test statistics. k, Scatter plots of the Log2 RPM values on canonical 
annotated TSSs (±100bp) in control and Setd2 knockdown ESCs. r = Pearson 
correlation. l, Venn diagram of intragenic TSSs having DECAP-seq signal > 6 
RPM showing single-base resolution overlap between control and SetD2 
knockdown ESCs. m, n, Venn diagrams of intragenic TSSs having DECAP-
seq signal > 6 RPM showing single-base resolution overlap between the 
indicated samples. Significance is given by the Hypergeometric Distribution 
test statistics. o, Pie-charts of the DECAP-seq reads distribution on TSSs > 6 
RPM in control knockdown (on the top) and Setd2 (on the bottom) ESCs. In 
green are shown the novel TSSs that overlap with RefSeq annotated TSS, in 
yellow all the common TSSs distributed on gene body and in pink the sample-
specific TSSs on gene body.  
 
 
Extended Data Figure 9: Internal transcription activation in Dnmt3b-/- 
ESCs show the same intragenic TSSs also in SetD2 knockdown cells. 
a, Genomic view of the indicated genes showing intragenic transcription 
initiation increase in Dnmt3b-/- and in shSetD2 WT cells. Lower part, sanger 
bisulfite sequencing of shCTR and shSetD2 WT ESCs on intragenic TSSs 
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previously described. b, Genomic views of the mapped reads from 
H3K36me3 (in WT ESCs) and Dnmt3b ChIP-seq datasets (in Mock or 
Dnmt3b-transfected Dnmt3b-/- ESCs). Both the WT or the catalytically inactive 
mutant (V725G) Dnmt3b showed intragenic binding enrichment. c, qPCR 
analysis of IgG and Dnmt3b ChIP experiments in Mock or Dnmt3b (WT and 
mutant V725G) transfected Dnmt3b-/- ESCs for the indicated intragenic 
regions. Error bars represent the standard deviation of at least 3 independent 
experiments. P-value was calculated against Mock condition by using t-test. 
(** p-value < 0.001). Primers used are reported in TableS1. d, Dot-blot 
analysis of genomic DNA isolated from Mock or Dnmt3b (WT and mutant 
V725G) transfected Dnmt3b-/- ESCs. Dot intensity quantification from three 
biological replicates revealed that Dnmt3b WT (but not the V725G mutant) 
significantly (p=0.003) increases global DNA 5mC. P-value was calculated 
against Mock condition by using t-test. e, qPCR analysis of MeDIP 
experiments in Mock or Dnmt3b (WT and mutant V725G) transfected Dnmt3b-
/- ESCs for the indicated intragenic regions. An intragenic significant increase 
of DNA methylation has been observed in Dnmt3b WT (but not mutant) 
transfected Dnmt3b-/- ESCs. Error bars represent the standard deviation of at 
least 3 independent experiments. P-value was calculated against Mock 
condition by using t-test. (** p-value < 0.001). Primers used are reported in 
Table S1. f, Genomic views of the RNA-seq mapped reads from the indicated 
samples. g, Scatter plots of the Log2 RPKM gene values in the indicated 
samples. r = Pearson correlation. Of note, Mock ESCs showed higher 
correlation with Dnmt3b mutant transfected ESCs (r = 0.99) with respect that 
Dnmt3b WT transfected ESCs (r = 0.95), thus suggesting that DNA 
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methylation enzymatic activity is the major driver of the Dnmt3b-dependent 
transcriptome alterations. h, Western blot of Dnmt3b-/- ESCs transfected with 
mock, Dnmt3b WT, Dnmt3b S277P, and Dnmt3b VW-RR. -Actin was used 
as protein loading control. I, j, qPCR analysis of ChIP and MeDIP experiments 
of the indicated regions in Dnmt3b mutant conditions. Specific impairment of 
Dnmt3b binding and DNA methylation is observed in both the mutants 
compared to the rescue by using WT Dnmt3b enzyme.  Error bars represent 
the standard deviation of at least 3 independent experiments. Primers used 
are reported in TableS1. 
 
 
Extended Data Figure 10:  Cryptic RNA transcripts are degraded in part 
by the  RNA exosome complex.   
a, RNA-seq profile of Dnmt3b-/- cells transfected with mock or Dnmt3b 
mutants. b, Scatter plots of the Log2 RPKM gene values in the indicated 
samples. r = Pearson correlation. c. Box plot of the ratio between normalized 
RNA-seq read counts (RPKM) for the second, the third, the intermediate 
(average) and the last over the first exons, in Dnmt3b-/- ESCs transfected with 
mock, Dnmt3b (WT) or mutants Dnmt3b (S277P and VW-RR). Significance is 
given by Wilcoxon Rank Sum test statistics. d, Pie-chart showing the 
percentage of transcripts having (intermediate/first exon ratio in Dnmt3b (WT 
or mutants) transfected Dnmt3b-/- ESCs vs. intermediate/first exon ratio in 
mock Dnmt3b-/- ESCs) Log2 fold-change (FC) > 1, < -1 or between -1 and 1.  
e, f, Histogram plot and western blot showing mRNA and protein levels of 
Dis3 and Rrp6 genes in control or Dis3/Rrp6 double knockdown (dKD) in 
 52 
Dnmt3b-/- ESCs. -Actin was used as protein loading control. g, Box plots 
showing the number of total TSS / gene on RefSeq annotated TSSs and on 
gene body in control or Dis3/Rrp6 dKD Dnmt3b-/- ESCs. Significance is given 
by Wilcoxon Rank Sum test statistics. h, Box plot of the normalized DECAP-
seq read counts (RPM) on the intragenic TSSs in the indicated samples. 
Significance is given by Wilcoxon Rank Sum test statistics. i, Scatter plots of 
the Log2 RPM values on canonical annotated TSSs(±100bp) of the indicated 
samples. r = Pearson correlation. j, Venn diagrams of intragenic TSSs having 
DECAP-seq signal > 6 RPM showing the single-base resolution overlap 
between the DECAP-seq experiments replicates performed in Dnmt3b-/- 
ESCs. Significance is given by the Hypergeometric Distribution test statistics. 
k, Pie-charts of the DECAP-seq reads distribution on TSSs > 6 RPM in control 
(on the left) and Dis3/Rrp6 KD (on the right) Dnmt3b-/- ESCs. In green are 
shown the novel TSSs that overlap with RefSeq annotated TSSs, in yellow all 
the common TSSs distributed on gene body and in pink the sample-specific 
TSSs on gene body. l, Scatter plots of the Log2 RPKM gene values in the 
indicated samples. r = Pearson correlation. m, Genomic views of the RNA-seq 
mapped reads from the indicated samples. n, Box plots of the ratio between 
normalized polyA RNA-seq read counts (RPKM) for the second and the first 
exon, the third and the first exon, the average of the intermediate (from the 4th 
to penultimate) and the first exon, the last and the first exon in WT (rep #2) 
and Dnmt3b-/- (rep #2 and cl. B77) ESCs. Significance is given by Wilcoxon 
Rank Sum test statistics. o, Pie-chart showing the percentage of transcripts 
having intermediate/first exon ratio (in Dnmt3b-/- rep #2 and clone B77 polyA 
RNA-seq) vs. intermediate/first exon ratio (in WT rep #2 polyA RNA-seq) Log2 
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fold-change > 1, < -1 or between -1 and 1. p, Box plots showing the number 
of total TSS / gene on RefSeq annotated TSSs and on gene body identified 
by DECAP-seq in the indicated RNA compartments. Significance is given by 
Wilcoxon Rank Sum test statistics. q, Scatter plots of the Log2 RPM values 
on canonical annotated TSSs (±100bp) in the indicated RNA compartments. r 
= Pearson correlation. r, Venn diagram of the common intragenic TSSs 
(defined as having RPM > 6 in both Dnmt3b-/- and WT ESCs) in the indicated 
RNA compartments. s, Box plot of the normalized DECAP-seq read counts 
(RPM) on the common (defined as having RPM > 6 in both Dnmt3b-/- and WT 
ESCs) intragenic TSSs in the indicated RNA compartments. 
 
Extended Data Figure 11: Loss of Dnmt3b generates partial intragenic 
starting RNAs that are as stable as canonical mRNAs. 
a, Genomic views of the RNA-seq mapped reads from the indicated samples. 
Genes with slow, medium and fast decay are shown. b, Gene Ontology (GO) 
analysis of the subsets of the mRNAs having fast decay (half-life lower of four 
hours) or slow decay (half-life higher than nine hours) in WT ESCs. The 
analysis revealed that fast decay mRNAs are mainly involved in cell cycle and 
transcription biological processes, while slow decay mRNAs are more related 
to metabolism and translation. This result is in agreement with that previously 
observed in mESCs54,55, thus suggesting the bona fide of the experiment. c, 
Scatter plot of the mRNAs half-life (in hours) in WT and Dnmt3b-/- ESCs. d, e, 
Box plots of the introns half-life (in hours) in WT and Dnmt3b-/- ESCs. Introns 
half-life is estimated by considering only the reads mapped on intronic 
regions. Introns half-life is generally lower with respect to the mRNAs half-life, 
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thus suggesting a less stability of the RNAs containing intronic parts. Introns 
half-life calculated in Dnmt3b-/- ESCs is significantly (p = 0.0016) higher with 
respect to that calculated in WT ESCs. Significance is given by Wilcoxon 
Rank Sum test statistics. f, g, Frequency distribution of introns and mRNA 
half-life among all introns in WT and Dnmt3b-/- ESCs. h, Genomic views of the 
RNA-seq mapped reads from the indicated samples. ART-seq reads derived 
only from the coding sequences (CDS) of the mRNAs. RNA-seq is shown as 
reference example. i, Scatter plots of the Log2 RPKM gene values in the 
indicated samples. r = Pearson correlation. j, Box plot of the normalized ART-
seq rep #2 read counts (RPKM) on the indicated RNA regions in WT and 
Dnmt3b-/- ESCs. k, Box plot of the normalized ART-seq read counts (RPKM, 
for both the biological replicates) on the introns in WT and Dnmt3b-/- ESCs. 
Significance is given by Wilcoxon Rank Sum test statistics 
 
 
 
Extended Data Figure 12: Models from of the obtained results. 
a, Scheme of the functional role of the Dnmt3b-dependent intragenic DNA 
methylation in ESCs. In WT cells the Dnmt3b is able to methylate gene bodies 
to favour a repressive chromatin inhibiting spurious entries of the RNA 
Polymerase II. In absence of Dnmt3b, gene bodies are hypomethylated, thus 
leading to RNA Pol II intragenic entries generating intragenic transcription 
initiation. b, Epigenetic crosstalk between RNA Pol II, SetD2 and Dnmt3b and 
relative H3K36me3 and 5mC chromatin modifications, unveils how the RNA 
 55 
Pol II, through the transcription elongation process, triggers a safety 
mechanism to ensure its transcription initiation fidelity.  
